Solutions We Offer

Chemistry solutions and process R&D

Innovative Chemistry

Explore state-of-the-art lab technologies

About SynZeal

SynZeal Research is an independent research driven company specialized in the custom synthesis of pharmacopeial & non-pharmacopeial reference standards, drug glucuronides, drug metabolites, Isotope labelled reference standards and focused compound libraries. As a research-driven organization, we have developed novel processes to make niche products required to pharmaceutical companies globally at various platform. We understand the industry research needs thoroughly and have earned reputation for being most reliable innovator of pharmaceutical reference standards worldwide.

LATEST EVENTS

Achieving ISO 17025 accreditation can be a significant milestone for our company, especially if we are involved in testing, calibration, or laboratory services. This accreditation demonstrates that our company meets international standards for quality and competence in laboratory activities. To make it an impactful event for our company,

UPCOMING EVENTS

The CPhI Worldwide event is a major international gathering for the pharmaceutical industry, and Japan is a great location for it in 2025. It's a great opportunity to network, discover innovations, and explore trends in the pharma sector. Start date : 09 Apr 2025 End date : 11 Apr 2025 Location : East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan

PAST EVENTS

CPhI India 2024 was an impactful event, providing invaluable opportunities to engage with our customers and gather insights to propel continuous improvement. It reaffirmed our dedication to delivering the highest quality reference standards across a wide range while aligning our upcoming offerings in advanced intermediates and APIs with valuable feedback.

Fluocinonide

Date: Thursday, April 28, 2022 /

Fluocinonide is a synthetic glucocorticoid receptor initiated by transcription of the ligand-receptor complex to the nucleus and transcriptional activation of genes containing glucocorticoid responsive elements. Fluocinonide has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Candida Keratitis/Endophthalmitis. It was patented in 1964 and approved for medical use in 1971.

OUR CLIENTS

SynZeal is committed to consistently enhancing our products and services to serve an expanding customer requirement.

ACCREDITATION

We are committed to excellence in medical research, proudly holding accreditations that ensure the highest standards of quality and ethics in our work. These certifications reflect our dedication to reliable and impactful outcomes.

Talk to our team of experts about how this can be justified to the regulatory agency using scientific justification supported by experimental results.

SCHEDULE MEETING WITH US

+91-7969-225-400 standards@synzeal.com +91-6357-003-635